WallStSmart
PROF

Profound Medical Corp

NASDAQ: PROF · HEALTHCARE · MEDICAL DEVICES

$7.22
-0.69% today

Updated 2026-05-06

Market cap
$248.97M
P/E ratio
P/S ratio
15.47x
EPS (TTM)
$-1.41
Dividend yield
52W range
$4 – $9
Volume
0.2M

Profound Medical Corp (PROF) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201420152016201720182019202020212022202320242025
Revenue$0.00$0.00$3.90M$1.91M$4.17M$7.30M$6.87M$6.68M$7.20M$10.17M$16.38M
Revenue growth (YoY)-51.0%+118.5%+75.0%-5.9%-2.8%+7.8%+41.2%+61.1%
Cost of revenue$119025.00$187008.00$2.41M$1.31M$1.78M$3.83M$3.92M$3.66M$2.82M$3.47M$4.71M
Gross profit$-119025.00$-187008.00$1.49M$604815.00$2.39M$3.47M$2.95M$3.02M$4.38M$6.70M$11.39M
Gross margin38.2%31.7%57.3%47.6%43.0%45.2%60.9%65.9%69.6%
R&D$2.31M$3.70M$7.43M$7.66M$7.54M$9.40M$9.91M$15.28M$14.69M$14.38M$16.15M$20.60M
SG&A$1.95M$4.39M$4.20M$4.72M$4.89M$5.79M$7.57M$10.31M$9.46M$9.17M$23.13M$32.05M
Operating income$-4.34M$-11.22M$-15.64M$-17.63M$-14.83M$-14.90M$-18.86M$-30.29M$-32.13M$-28.62M$-31.47M$-41.98M
Operating margin-451.9%-776.0%-357.1%-258.3%-440.7%-480.9%-397.5%-309.6%-256.3%
EBITDA$-6.31M$-11.15M$-15.56M$-16.78M$-13.24M$-12.53M$-19.50M$-28.65M$-26.60M$-26.78M$-25.59M$-41.41M
EBITDA margin-430.2%-693.1%-300.1%-266.9%-416.8%-398.2%-372.0%-251.7%-252.8%
EBIT$-6.40M$-11.23M$-15.75M$-17.65M$-14.92M$-14.04M$-21.03M$-30.53M$-28.21M$-27.93M$-26.48M$-41.98M
Interest expense$143014.00$4.05M$615868.00$1.07M$755374.00$1.04M$543000.00$66410.00$167105.00$770000.00
Income tax$410407.00$-523222.00$10456.00$58944.00$169441.00$147000.00$45000.00$105000.00$287000.00$-128000.00$-1903.00
Effective tax rate-5.3%4.2%-0.1%-0.4%-1.1%-1.0%-0.2%-0.3%-1.0%0.4%0.0%0.0%
Net income$-8.20M$-11.80M$-12.15M$-14.97M$-15.24M$-15.22M$-21.62M$-30.70M$-28.67M$-28.57M$-26.48M$42.32M
Net income growth (YoY)-43.8%-2.9%-23.2%-1.8%+0.1%-42.0%-42.0%+6.6%+0.3%+7.3%+259.8%
Profit margin-383.8%-797.9%-364.7%-296.0%-446.7%-429.1%-396.8%-260.4%258.4%